Clinical Trial Update: Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the hemodynamic effects of chronic spironolactone and/or propranolol in patients with alcoholic cirrhosis. The trial status is terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Cirrhosis

Drugs mentioned

• Aldactone (spironolactone)
• Inderal (propranolol)

Snippet

Sponsor: University Hospital, Angers | Conditions: Alcoholic Cirrhosis | Phase 4 | Status: TERMINATED